Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
1.360
+0.020 (1.49%)
At close: Oct 30, 2025, 4:00 PM EDT
1.360
0.00 (0.00%)
After-hours: Oct 30, 2025, 8:00 PM EDT
MTNB Market Cap
MTNB has a market cap or net worth of $7.55 million as of October 30, 2025. Its market cap has decreased by -52.50% in one year.
Market Cap
7.55M
Enterprise Value
3.56M
1-Year Change
-52.50%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since March 2, 2017, MTNB's market cap has decreased from $223.50M to $7.55M, a decrease of -96.62%. That is a compound annual growth rate of -32.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 29, 2025 | 6.80M | 161.54% |
| Dec 31, 2024 | 2.60M | -94.47% |
| Dec 29, 2023 | 47.00M | -56.64% |
| Dec 30, 2022 | 108.40M | -50.37% |
| Dec 31, 2021 | 218.40M | -19.41% |
| Dec 31, 2020 | 271.00M | -26.64% |
| Dec 31, 2019 | 369.40M | 452.17% |
| Dec 31, 2018 | 66.90M | -37.94% |
| Dec 29, 2017 | 107.80M | -51.77% |
| Mar 2, 2017 | 223.50M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.90B |
| Johnson & Johnson | 457.53B |
| AbbVie | 402.83B |
| UnitedHealth Group | 331.46B |
| AstraZeneca | 259.35B |
| Novartis AG | 250.89B |
| Novo Nordisk | 235.38B |
| Abbott Laboratories | 221.35B |